Premium
O1‐02‐04: Florbetapir F 18 ( 18 F‐AV‐45) PET amyloid imaging predicts progression of cognitive impairment: A longitudinal clinical follow up study
Author(s) -
Sperling Reisa A.,
Doraiswamy P. Murali,
Johnson Keith,
Reiman Eric M.,
Sabbagh Marwan N.,
Sadowsky Carl H.,
Carpenter Alan,
Clark Chris M.,
Flitter Mathew,
Pontecorvo Michael J.,
Skovronsky Daniel M.
Publication year - 2010
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2010.05.212
Subject(s) - clinical dementia rating , medicine , dementia , cognitive impairment , cognition , alzheimer's disease , amyloid (mycology) , cognitive decline , pittsburgh compound b , nuclear medicine , pathology , disease , psychiatry